🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.7050
-0.1250 (-15.06%)
At close: Nov 20, 2026, 4:00 PM EST
0.7220
+0.0170 (2.41%)
After-hours: Nov 20, 2026, 7:45 PM EST

FibroBiologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
8.289.249.236.523.321.06
Research & Development
7.487.414.52.371.150.52
Operating Expenses
15.7616.6513.748.894.471.58
Operating Income
-15.76-16.65-13.74-8.89-4.47-1.58
Interest Expense
-0.22-0.2-0.02-0.15-0.65-0
Interest & Investment Income
0.080.250.25---
Other Non Operating Income (Expenses)
-0.51-2.042.35-7.45--
Pretax Income
-16.41-18.65-11.16-16.49-5.12-1.58
Net Income
-16.41-18.65-11.16-16.49-5.12-1.58
Preferred Dividends & Other Adjustments
---2.57--
Net Income to Common
-16.41-18.65-11.16-19.06-5.12-1.58
Net Income Growth
------
Shares Outstanding (Basic)
622110
Shares Outstanding (Diluted)
622110
Shares Change
210.86%35.85%16.45%-222.64%-
EPS (Basic)
-2.77-8.35-6.79-13.50-3.63-3.62
EPS (Diluted)
-2.77-8.35-6.79-13.50-3.63-3.62
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-13.59-16.66-12.09-6.9-4.07-1.41
Free Cash Flow Per Share
-2.29-7.46-7.35-4.88-2.88-3.22
EBITDA
-15.5-16.41-13.58-8.84--
D&A For EBITDA
0.260.240.160.05--
EBIT
-15.76-16.65-13.74-8.89-4.47-1.58
SEC Filings: 10-K · 10-Q